Safety and effectiveness of remdesivir for the treatment of COVID-19 patients with end-stage renal disease: A retrospective cohort study

CONCLUSION: Remdesivir is safe for use in patients with COVID-19 and ESRD; no increased adverse effects were noted compared with patients without ESRD. However, the effectiveness of remdesivir use in patients with COVID-19 and ESRD remains uncertain.PMID:38135644 | DOI:10.1016/j.jmii.2023.12.003

Source: Journal of Microbiology, Immunology, and Infection - December 22, 2023 Category: Microbiology Authors: Yan-Bo Huang Chip-Jin Ng Cheng-Hsun Chiu Chung-Hsien Chaou Shi-Ying Gao Shou-Yen Chen Source Type: research